Methionine adenosyltransferase 1 alpha (MAT1A), which encodes the SAM synthesizing enzyme, was demonstrated to be reduced in the patients with ALD, and MAT1A knock-out mice showed increased susceptibility to hepatocarcinogenesis leading to development of HCC [36]. Here, MAT1A is linked to hepatocellular carcinoma.